Skip to content
Screener

Globus Medical GMED Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Bioventus logo
BioventusBVS
$230K-64.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
Medtronic logo
MedtronicMDT
3D Systems logo
3D SystemsDDD

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$11.57B+44.1%
Enterprise value$11.17B+41.1%
P/E21.6×-0.9×
P/S3.7×+0.6×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Provision for excess and obsolete inventory9,79510,933
Amortization of acquisition accounting fair value step up12,673
Stock-based compensation expense26,00026,823
Allowance for expected credit losses10,3984,554
Change in fair value of business acquisition liabilities16,0595,389
Change in deferred income taxes15,748(41,236)
(Gain)/loss on disposal of assets, net5,5586,131
Payment of business acquisition-related liabilities(2,596)(15,764)

Item 1. Financial Statements

FAQ

What is Globus Medical's accounts receivable, credit loss expense (reversal)?
Globus Medical (GMED) reported accounts receivable, credit loss expense (reversal) of $5.12M in Q2 2026.
How has Globus Medical's accounts receivable, credit loss expense (reversal) changed year-over-year?
Globus Medical's accounts receivable, credit loss expense (reversal) increased by 279.9% year-over-year, from $1.35M to $5.12M.
What is the long-term trend for Globus Medical's accounts receivable, credit loss expense (reversal)?
Over 2 years (2021 to 2025), Globus Medical's accounts receivable, credit loss expense (reversal) has grown at a 191.9% compound annual growth rate (CAGR), from $1.2M to $10.22M.
What does accounts receivable, credit loss expense (reversal) mean?
Accounts Receivable, Credit Loss Expense (Reversal)

Ask your AI about Globus Medical's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude